KO
Kufrevioglu, Omer Irfan
18 papers · 392 citations · 2021–2026
Publications
18
Citations
392
Years
6
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Unnatural amino acid compounds as potent multi-target inhibitors of aldose reductase, α-glucosidase, and α-amylase: integrated in vitro, SAR, and molecular dynamics insights
|
2026 | Article | 0 |
|
Synthesis, characterization, and lipoxygenase inhibition of salicylaldehyde-derived schiff base metal complexes: enzymatic and in silico evaluation using quinoa lipoxygenase
|
2026 | Article | 0 |
|
<i>In vitro</i> inhibition potency of malononitrile derivatives on the activity of two pentose phosphate pathway enzymes: accompanied by molecular docking evaluation
|
2025 | Article | 3 |
|
Assessment of Polyphenol Oxidase Inhibition, Antibacterial, and Antioxidant Activity of Some Chalcone Derivatives: Experimental and Computational Approaches
|
2025 | Article | 5 |
|
Comprehensive characterization of purified naringinase: effect on naringin content, antioxidant activity, phenolic profile, and grapefruit juice quality
|
2025 | Article | 0 |
|
Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesterase
|
2024 | Article | 65 |
|
Dynamics of small molecule-enzyme interactions: Novel benzenesulfonamides as multi-target agents endowed with inhibitory effects against some metabolic enzymes
|
2024 | Article | 26 |
|
Affinity gel synthesis from the p-aminobenzoic acid derivative 4-ami-no-2-methylbenzoic acid and purification of polyphenol oxidase from various plant sources
|
2024 | Article | 6 |
|
Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies
|
2024 | Article | 73 |
|
Molecular Docking Studies and the Effect of Fluorophenylthiourea Derivatives on Glutathione-Dependent Enzymes
|
2023 | Article | 24 |
|
Structure-Activity Relationship of Methyl 4-Aminobenzoate Derivatives as Being Drug Candidate Targeting Glutathione Related Enzymes: <i>in Vitro</i> and <i>in Silico</i> Approaches
|
2023 | Article | 11 |
|
Some indazoles as alternative inhibitors for potato polyphenol oxidase
|
2022 | Article | 16 |
|
Screening of in vitro and in silico effect of Fluorophenylthiourea compounds on glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase enzymes
|
2022 | Article | 17 |
|
Cytotoxic effect, enzyme inhibition, and in silico studies of some novel <i>N</i>-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif
|
2022 | Article | 77 |
|
Methyl benzoate derivatives as inhibitors of pentose phosphate pathway, which promotes cancer progression and drug resistance: An in silico study supported by in vitro results
|
2022 | Article | 7 |
|
<i>In vitro</i> and <i>in silico</i> interactions of antiulcer, glucocorticoids and urological drugs on human carbonic anhydrase I and II isozymes
|
2022 | Article | 6 |
|
Calcium Channel Blockers: The Effect of Glutathione S-Transferase Enzyme Activity and Molecular Docking Studies
|
2021 | Article | 21 |
|
A study on the effects of inhibition mechanism of curcumin, quercetin, and resveratrol on human glutathione reductase through <i>in vitro</i> and <i>in silico</i> approaches
|
2021 | Article | 35 |